21 May 2013
Keywords: novartis, buy, remaining, interest, systemix, swiss, drug
Article | 20 January 1997
Swiss drug major Novartis has entered into a definitive agreement withPalo Alto, California-based biotechnology company SyStemix Inc to
acquire all ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 January 1997
13 January 1997
20 May 2013
© 2013 thepharmaletter.com